Papillary carcinoma of the thyroid: High expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness

Thyroid

Volumn 23, Issue 9, 2013, Pages 1127-1137

  Scarpino, Stefania ^a   Duranti, Enrico ^a   Giglio, Simona ^a   Di Napoli, Arianna ^a   Galafate, Dino ^a   Del Bufalo, Donatella ^b   Desideri, Marianna ^b   Socciarelli, Fabio ^a   Stoppacciaro, Antonella ^a   Ruco, Luigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; RNA; CD82 PROTEIN, HUMAN; CYCLOOXYGENASE 2 INHIBITOR; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA; TUMOR INVASION; UPREGULATION; ANIMAL; CARCINOMA; CELL MOTION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PRIMARY CELL CULTURE; SECONDARY; SIGNAL TRANSDUCTION; THYROID TUMOR; TUMOR CELL CULTURE; TUMOR CELL LINE; YOUNG ADULT;

ADULT; AGED; ANIMALS; ANTIGENS, CD82; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84884129797     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0421     Document Type: Article

References (38)

1. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC 1995 KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884-886.
2. Tonoli H, Barrett JC 2005 CD82 metastasis suppressor gene: a potential target for new therapeutics? Trends Mol Med 11:563-570.
3. Miranti CK 2009 Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis. Cell Signal 21:196-211.
4. Phillips KK, Welch DR, Miele ME, Lee JH, Wei LL, Weissman BE 1996 Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res 56:1222-1227.
5. Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M 1996 Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 56:1751-1755.
6. Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC, Isaacs JT 1996 Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 56:4387-4390.
7. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Bü chler MW 1996 KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 56:4876-4880.
8. Huang CI, Kohno N, Ogawa E, Adachi M, Taki T, Miyake M 1998 Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 153:973-983.
9. Yu Y, Yang JL, Markovic B, Jackson P, Yardley G, Barrett J, Russell PJ 1997 Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin Cancer Res 3:1045-1049.
10. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC 1999 Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 59:5724-5731.
11. Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME 2001 Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 61:5284-5288.
12. Takeda T, Hattori N, Tokuhara T, Nishimura Y, Yokoyama M, Miyake M 2007 Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res 67:1744-1749.
13. Berditchevski F, Odintsova E 1999 Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J Cell Biol 146:477-492.
14. He B, Liu L, Cook GA, Grgurevich S, Jennings LK, Zhang XA 2005 Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J Biol Chem 280:3346-3354.
15. Sridhar SC, Miranti CK 2006 Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 25: 2367-2378.
16. Ruseva Z, Geiger PX, Hutzler P, Kotzsch M, Luber B, Schmitt M, Gross E, Reuning U 2009 Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation. Exp Cell Res 315:1759-1771.
17. Odintsova E, Sugiura T, Berditchevski F 2000 Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol 10:1009-1012.
18. Takahashi M, Sugiura T, Abe M, Ishii K, Shirasuna K 2007 Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration. Int J Cancer 121: 1919-1929.
19. Yang JM, Peng ZH, Si SH, Liu WW, Luo YH, Ye ZY 2008 KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models. Liver Int 28:132-139.
20. Liu X, Guo XZ, Zhang WW, Lu ZZ, Zhang QW, Duan HF, Wang LS 2011 KAI1 inhibits HGF-induced invasion of pancreatic cancer by sphingosine kinase activity. Hepatobiliary Pancreat Dis Int 10:201-208.
21. Ruco LP, Ranalli T, Marzullo A, Bianco P, Prat M, Comoglio PM, Baroni CD 1996 Expression of Met protein in thyroid tumours. J Pathol 180:266-270.
22. Scarpino S, Stoppacciaro A, Colarossi C, Cancellario F, Marzullo A, Marchesi M, Biffoni M, Comoglio PM, Prat M, Ruco LP 1999 Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid. J Pathol 189:570-575.
23. Scarpino S, Duranti E, Stoppacciaro A, Pilozzi E, Natoli G, Sciacchitano S, Luciani E, Ruco L 2009 COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness. J Pathol 218:487-494.
24. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow L, Copland JA, Smallridge RC, Haugen BR 2008 DNA profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93:4331-4441.
25. Ito Y, Yoshida H, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma K, Miyauchi A 2003 KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma. Pathol Res Pract 199:79-83.
26. Chen Z, Mustafa T, Trojanowicz B, Brauckhoff M, Gimm O, Schmutzler C, Köhrle J, Holzhausen HJ, Kehlen A, Klonisch T, Finke R, Dralle H, Hoang-Vu C 2004 CD82, and CD63 in thyroid cancer Int J Mol Med 14:517-527.
27. Tsujii M, Kawano S, DuBois RN 1997 Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94:3336-3340.
28. Fenwick SW, Toogood GJ, Lodge JP, Hull MA 2003 The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology 125:716-729.
29. Yao M, Kargman S, Lam EC, Kelly CR, Zheng Y, Luk P, Kwong E, Evans JF, Wolfe MM 2003 Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res 63:586-592.
30. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A 2009 The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30:377-386.
31. Sheng H, Shao J, Washington MK, DuBois RN 2001 Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276:18075-18081.
32. Pai R, Nakamura T, Moon WS, Tarnawski AS 2003 Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J 17:1640-1647.
33. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF 2003 Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915-925.
34. Zanetti A, Stoppacciaro A, Marzullo A, Ciabatta M, Fazioli F, Prat M, Comoglio PM, Baroni CD, Ruco LP 1998 Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. J Pathol 186:287-291.
35. Scarpino S, Cancellario d'Alena F, Di Napoli A, Pasquini A, Marzullo A, Ruco LP 2004 Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid. J Pathol 202:352-358.
36. Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, Chen C, Chung CH, Huber O, Rose DW, Sawyers CL, Rosenfeld MG, Baek SH 2005 Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 434:921-926.
37. Baek SH 2006 A novel link between SUMO modification and cancer metastasis. Cell Cycle 5:1492-1495.
38. Tsai YC, Mendoza A, Mariano JM, Zhou M, Kostova Z, Chen B, Veenstra T, Hewitt SM, Helman LJ, Khanna C, Weissman AM 2007 The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med 13:1504-1509.